Pulmonary Disease, Chronic Obstructive study: Coherent Breathing Group A
Official title Comparative Effects of Coherent Breathing and Regular Paced Breathing on Dyspnea and Pulmonary Function in Patients With Chronic Obstructive Pulmonary Disease
ClinicalTrials.gov ID: NCT07875036
What this study is testing
- What it's testing
- The study wants to find out whether coherent breathing or regular paced breathing reduces shortness of breath and improves lung function in COPD patients.
- Who it's for
- Adults who have chronic obstructive pulmonary disease.
- What's involved
- Participants will be taught a breathing technique (either coherent or regular paced breathing) and will practice it as instructed, with follow‑up visits for monitoring and tests.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 75
You may be able to join if
- Age between 40-75 years.
- Both genders (male and females).
- Diagnosed COPD mild to moderate stage according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification: Mild: FEV1 ≥ 80%...
- Diagnosed with COPD for at least 6 months prior to enrollment in study
- Resting SpO₂ ≥ 90% on room air
You likely can't join if
- Severe and very severe stage of COPD according to GOLD classification
- Patients having acute exacerbation of COPD with in the last 4 weeks
- Hemodnamically unstable patients
- Current smokers (active smoking or individuals using any tobacco product within the 6 months)
- Other sgnificant respiratory diseases (e.g., asthma, bronchiectasis, ILD, active tuberculosis)
- Patients unable to follow commands/instructions
See the full eligibility criteria
- Age between 40-75 years.
- Both genders (male and females).
- Diagnosed COPD mild to moderate stage according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification: Mild: FEV1 ≥ 80% predicted Moderate: FEV1 fall between 50-79%
- Diagnosed with COPD for at least 6 months prior to enrollment in study
- Resting SpO₂ ≥ 90% on room air
- Severe and very severe stage of COPD according to GOLD classification
- Patients having acute exacerbation of COPD with in the last 4 weeks
- Hemodnamically unstable patients
- Current smokers (active smoking or individuals using any tobacco product within the 6 months)
- Other sgnificant respiratory diseases (e.g., asthma, bronchiectasis, ILD, active tuberculosis)
- Patients unable to follow commands/instructions
- Patients currently participating in any other structured pulmonary rehabilitation or breathing intervention program
The study team makes the final eligibility decision.
Where it is enrolling
- Rawalpindi, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Rawalpindi, Pakistan. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.